What is the current stock price of Mabion S.A. (MAB.WA)?

As of the latest market data, Mabion S.A. (MAB.WA) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Mabion S.A. (MAB.WA) pay a dividend?

Based on current data, Mabion S.A. does not have a confirmed active dividend policy.

What is the market cap of Mabion S.A.?

The current market capitalization of Mabion S.A. (MAB.WA) is approximately unavailable.

MAB.WA

Mabion S.A.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.

Sector

Healthcare

Industry

Biotechnology

Employees

206

IPO Date

2010-08-10

Beta

0.58

Websitewww.mabion.eu↗